- Type / Class
- Equity / Common Stock
- Shares outstanding
- 238,388,839
- Total 13F shares
- 203,746,953
- Share change
- -6,291,185
- Total reported value
- $3,496,535,119
- Put/Call ratio
- 49%
- Price per share
- $17.15
- Number of holders
- 316
- Value change
- -$114,107,061
- Number of buys
- 182
- Number of sells
- 157
Quarterly Holders Quick Answers
What is CUSIP 000899104?
CUSIP 000899104 identifies ADMA - ADMA BIOLOGICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 000899104:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
16%
|
38,269,434
|
$765,005,986 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.6%
|
18,118,494
|
$362,188,696 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
5.5%
|
13,004,993
|
$259,969,810 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
5.3%
|
12,619,769
|
$252,269,182 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
3.6%
|
8,599,618
|
$171,906,371 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
2.8%
|
6,577,877
|
$131,491,761 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
5,381,985
|
$107,606,487 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.2%
|
5,264,095
|
$105,229,259 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.9%
|
4,454,400
|
$89,043,456 | — | 30 Sep 2024 | |
| AWM Investment Company, Inc. |
13F
|
Company |
1.9%
|
4,452,677
|
$89,009,013 | — | 30 Sep 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.8%
|
4,209,653
|
$84,150,982 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.7%
|
4,132,019
|
$82,599,060 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
4,024,659
|
$80,449,493 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.5%
|
3,667,196
|
$73,307,248 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.5%
|
3,591,375
|
$71,791,586 | — | 30 Sep 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.5%
|
3,474,455
|
$69,454,355 | — | 30 Sep 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.3%
|
3,094,457
|
$61,858,000 | — | 30 Sep 2024 | |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
|
10%+ Owner · Company |
0.44%
from 13F
|
13,262,375
|
$59,945,935 | — | 28 Sep 2021 | |
| OBERWEIS ASSET MANAGEMENT INC/ |
13F
|
Company |
1.2%
|
2,907,080
|
$58,112,529 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
2,611,677
|
$52,207,424 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
2,429,688
|
$48,569,462 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
2,401,533
|
$48,006,645 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.88%
|
2,100,134
|
$41,982,000 | — | 30 Sep 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.86%
|
2,055,803
|
$41,095,502 | — | 30 Sep 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.88%
|
2,086,322
|
$40,443,352 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
0.82%
|
1,944,831
|
$38,877,172 | — | 30 Sep 2024 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.78%
|
1,870,000
|
$37,381,300 | — | 30 Sep 2024 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.73%
|
1,749,244
|
$34,967,388 | — | 30 Sep 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.68%
|
1,627,693
|
$32,537,584 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.58%
|
1,373,418
|
$27,454,619 | — | 30 Sep 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.57%
|
1,360,000
|
$27,186,400 | — | 30 Sep 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.5%
|
1,194,221
|
$23,872,478 | — | 30 Sep 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.48%
|
1,138,323
|
$22,755,000 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.47%
|
1,116,930
|
$22,327,431 | — | 30 Sep 2024 | |
| Mesirow Institutional Investment Management, Inc. |
13F
|
Company |
0.42%
|
1,001,903
|
$20,028,041 | — | 30 Sep 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.35%
|
822,621
|
$16,444,194 | — | 30 Sep 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.34%
|
808,042
|
$16,152,763 | — | 30 Sep 2024 | |
| Ophir Asset Management Pty Ltd |
13F
|
Company |
0.32%
|
763,074
|
$15,253,849 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.31%
|
750,788
|
$15,008,252 | — | 30 Sep 2024 | |
| CASTLEARK MANAGEMENT LLC |
13F
|
Company |
0.29%
|
692,966
|
$13,852,390 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.28%
|
672,837
|
$13,450,012 | — | 30 Sep 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.28%
|
664,985
|
$13,293,050 | — | 30 Sep 2024 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.28%
|
658,900
|
$13,171,411 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.27%
|
648,275
|
$12,959,017 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.26%
|
627,130
|
$12,536,328 | — | 30 Sep 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.26%
|
625,719
|
$12,508,123 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.26%
|
615,198
|
$12,297,786 | — | 30 Sep 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
589,313
|
$11,780,367 | — | 30 Sep 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.25%
|
588,874
|
$11,771,591 | — | 30 Sep 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.24%
|
561,228
|
$11,218,947 | — | 30 Sep 2024 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q4 2024
As of 31 Dec 2024,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
316 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
203,746,953 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, Invesco Ltd., MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, Nuveen Asset Management, LLC, DEUTSCHE BANK AG\, and AMERICAN CENTURY COMPANIES INC.
This page lists
317
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
300
Q4 2024 holders
316
Holder diff
16
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.